Athyros, V. G., Doumas, M., Imprialos, K. P., Stavropoulos, K., Georgianou, E., Katsimardou, A., & Karagiannis, A. (2018). Diabetes and lipid metabolism. Hormones, 17, 61-67. doi:
https://doi.org/10.1007/s42000-018-0014-8
Charles, M. A., & Leslie, R. D. (2021). Diabetes: concepts of β-cell organ dysfunction and failure would lead to earlier diagnoses and prevention. Diabetes, 70(11), 2444-2456. doi:
https://doi.org/10.2337/dbi21-0012
Dixit, V. D. (2012). Nlrp3 inflammasome activation in type 2 diabetes: is it clinically relevant? Diabetes, 62(1), 22. doi:
https://doi.org/10.2337/db12-1115
Feingold, K. R., & Grunfeld, C. (2023). Diabetes and dyslipidemia. In Diabetes And Cardiovascular Disease (pp. 425-472). Springer. doi:
https://doi.org/10.1007/978-3-031-13177-6_14
Feng, J., Zhang, Q., Chen, B., Chen, J., Wang, W., Hu, Y., . . . Huang, H. (2024). Effects of high-intensity intermittent exercise on glucose and lipid metabolism in type 2 diabetes patients: a systematic review and meta-analysis. Frontiers in Endocrinology, 15, 1360998. doi:
https://doi.org/10.3389/fendo.2024.1360998
Gora, I. M., Ciechanowska, A., & Ladyzynski, P. (2021). NLRP3 inflammasome at the interface of inflammation, endothelial dysfunction, and type 2 diabetes. Cells, 10(2), 314. doi:
https://doi.org/10.3390/cells10020314
Grant, R. W., & Dixit, V. D. (2013). Mechanisms of disease: inflammasome activation and the development of type 2 diabetes. Frontiers in immunology, 4, 50. doi:
https://doi.org/10.3389/fimmu.2013.00050
Jelleyman, C., Yates, T., O'Donovan, G., Gray, L. J., King, J. A., Khunti, K., & Davies, M. J. (2015). The effects of high‐intensity interval training on glucose regulation and insulin resistance: a meta‐analysis. Obesity Reviews, 16(11), 942-961. doi:
https://doi.org/10.1111/obr.12317
Kanaley, J. A., Colberg, S. R., Corcoran, M. H., Malin, S. K., Rodriguez, N. R., Crespo, C. J., . . . Zierath, J. R. (2022). Exercise/physical activity in individuals with type 2 diabetes: a consensus statement from the American College of Sports Medicine. Medicine and science in sports and exercise, 54(2), 353. doi:
https://doi.org/10.1249/MSS.0000000000002800
Keating, S. E., Hackett, D. A., Parker, H. M., O’Connor, H. T., Gerofi, J. A., Sainsbury, A., . . . George, J. (2015). Effect of aerobic exercise training dose on liver fat and visceral adiposity. Journal of hepatology, 63(1), 174-182. doi:
https://doi.org/10.1016/j.jhep.2015.02.022
Kim, H., Lee, D. S., An, T. H., Park, H.-J., Kim, W. K., Bae, K.-H., & Oh, K.-J. (2021). Metabolic spectrum of liver failure in type 2 diabetes and obesity: from NAFLD to NASH to HCC. International journal of molecular sciences, 22(9), 4495. doi:
https://doi.org/10.3390/ijms22094495
Leandro, C. G., Levada, A. C., Hirabara, S. M., MANHAS-DE-CASTRO, R., De-Castro, C. B., Curi, R., & Pithon-Curi, T. C. (2007). Aprogram of moderate physical training for wistar rats based on maximal oxygen consumption. The Journal of Strength & Conditioning Research, 21(3), 751-756.
Li, Q., Zhao, Z., Si, K., Zhou, J., Liu, H., & Lin, R. (2021). Correlation between the levels of NLRP3, Hcy, IL-1β, IL-18 and the prognosis in patients with hemorrhagic stroke. American Journal of Translational Research, 13(4), 2883. URL:
https://pmc.ncbi.nlm.nih.gov/articles/PMC8129339/
Liang, F., Huang, T., Li, B., Zhao, Y., Zhang, X., & Xu, B. (2020). High-intensity interval training and moderate-intensity continuous training alleviate β-amyloid deposition by inhibiting NLRP3 inflammasome activation in APPswe/PS1dE9 mice. Neuroreport, 31(5), 425-432. doi:
https://doi.org/10.1097/WNR.0000000000001429
Lindfors, A., Strandberg, R., & Hagström, H. (2025). Screening for advanced liver fibrosis due to metabolic dysfunction-associated steatotic liver disease alongside retina scanning in people with type 2 diabetes: a cross-sectional study. The lancet gastroenterology & hepatology, 10(2), 125-137.
Liu, J., Jia, S., Yang, Y., Piao, L., Wang, Z., Jin, Z., & Bai, L. (2023). Exercise induced meteorin-like protects chondrocytes against inflammation and pyroptosis in osteoarthritis by inhibiting PI3K/Akt/NF-κB and NLRP3/caspase-1/GSDMD signaling. Biomedicine & Pharmacotherapy, 158, 114118. doi:
https://doi.org/10.1016/j.biopha.2022.114118
Lu, S., Li, Y., Qian, Z., Zhao, T., Feng, Z., Weng, X., & Yu, L. (2023). Role of the inflammasome in insulin resistance and type 2 diabetes mellitus. Frontiers in immunology, 14, 1052756. doi:
https://doi.org/10.3389/fimmu.2023.1052756
Mallet, V., Parlati, L., Martinino, A., Pereira, J. P. S., Jimenez, C. N., Sakka, M., . . . Meritet, J.-F. (2022). Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitus. Journal of hepatology, 76(2), 265-274. doi:
https://doi.org/10.1016/j.jhep.2021.09.030
Mateo-Gallego, R., Madinaveitia-Nisarre, L., Giné-Gonzalez, J., Bea, A. M., Guerra-Torrecilla, L., Baila-Rueda, L., . . . Lamiquiz-Moneo, I. (2022). The effects of high-intensity interval training on glucose metabolism, cardiorespiratory fitness and weight control in subjects with diabetes: Systematic review a meta-analysis. Diabetes research and clinical practice, 190, 109979. doi:
https://doi.org/10.1016/j.diabres.2022.109979
Menini, S., Iacobini, C., Vitale, M., & Pugliese, G. (2020). The inflammasome in chronic complications of diabetes and related metabolic disorders. Cells, 9(8), 1812. doi:
https://doi.org/10.3390/cells9081812
Mobasheri, L., Ahadi, M., Namdar, A. B., Alavi, M. S., Bemidinezhad, A., Farahi, S. M. M., . . . Ghorbani, A. (2023). Pathophysiology of diabetic hepatopathy and molecular mechanisms underlying the hepatoprotective effects of phytochemicals. Biomedicine & Pharmacotherapy, 167, 115502. doi:
https://doi.org/10.1016/j.biopha.2023.115502
Qadri, S., & Yki-Järvinen, H. (2024). Surveillance of the liver in type 2 diabetes: important but unfeasible? diabetologia, 1-13. doi:
https://doi.org/10.1007/s00125-024-06087-7
Smith, A. (2024). Impact of high-intensity interval training on cardiac health in middle-aged adults. Revista multidisciplinar de las Ciencias del Deporte, 24(96).
Solano, M. P., & Goldberg, R. B. (2006). Lipid management in type 2 diabetes. Clinical diabetes, 24(1), 27-33.
Srinivasan, K., Viswanad, B., Asrat, L., Kaul, C., & Ramarao, P. (2005). Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacological research, 52(4), 313-320. doi:
https://doi.org/10.1016/j.phrs.2005.05.004
Stefan, N., & Cusi, K. (2022). A global view of the interplay between non-alcoholic fatty liver disease and diabetes. The lancet Diabetes & endocrinology, 10(4), 284-296.
Zhang, L., Ai, C., Bai, M., Niu, J., & Zhang, Z. (2022). NLRP3 inflammasome/pyroptosis: a key driving force in diabetic cardiomyopathy. International journal of molecular sciences, 23(18), 10632. doi:
https://doi.org/10.3390/ijms231810632